CHICAGO TRUST Co NA lessened its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 28.1% in the second quarter, HoldingsChannel.com reports. The fund owned 2,983 shares of the company’s stock after selling 1,166 shares during the period. CHICAGO TRUST Co NA’s holdings in Colgate-Palmolive were worth $271,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently modified their holdings of the company. Westend Capital Management LLC grew its position in shares of Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares during the period. Saudi Central Bank bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $29,000. Ransom Advisory Ltd bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $33,000. Finally, Y.D. More Investments Ltd bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $37,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
CL has been the subject of several research analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating for the company in a report on Monday, August 4th. Barclays lifted their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 15th. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Finally, UBS Group dropped their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $98.00.
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $81.14 on Thursday. The firm has a 50 day moving average of $84.49 and a 200-day moving average of $88.94. The stock has a market capitalization of $65.58 billion, a PE ratio of 22.79, a PEG ratio of 4.17 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $78.76 and a 12 month high of $104.49.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 EPS. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.43%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Calculate Return on Investment (ROI)
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- The Basics of Support and Resistance
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.